Oliveros, Gilbert .
HRN: 24-05-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/15/2023
11/22/2023
IV
2.2
Q6H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes